Dual diagnosis treatment for Palm Beach Gardens — one team, both diagnoses, together.
A specialist outpatient program for clients in Palm Beach Gardens. PHP, IOP, in-house psychiatry, sober-living network, family programming. Same admissions team, 24/7.
Start the conversation Or call directly — (561) 464-4077Local options exist. This is the clinical specialist.
For Palm Beach Gardens residents in PGA National, Mirasol, or BallenIsles, RECO Health's Delray Beach campus is a 35-minute drive south on I-95 — and one of the few programs in South Florida where addiction psychiatry, MAT, psychotropic prescribing, trauma therapy, TMS, and ketamine services all sit under one clinical roof. Both diagnoses are managed by the same team, on the same plan, with medication interactions flagged in real time rather than lost across three uncoordinated prescribers. Screening at intake uses the PHQ-9, PCL-5, GAD-7, MDQ, and ASRS, and level of care is scored against all six ASAM Criteria dimensions before anyone commits to a plan.
Palm Beach Gardens sits about 25 miles north of RECO Health’s Delray Beach campus — a 35-minute drive down I-95 that puts residents of PGA National, BallenIsles, Mirasol, Frenchman’s Reserve, and Old Palm within reach of a level of integrated care that outpatient practices in northern Palm Beach County are not staffed to deliver. For adults carrying both a substance use disorder and a co-occurring psychiatric diagnosis, treating one condition while the other goes unaddressed is the most reliable path to relapse. RECO Health’s dual diagnosis treatment program is built around a single premise: both diagnoses, one team, one plan, one building.
Why sequential treatment fails for co-occurring disorders
The research base on co-occurring disorders is unambiguous. “Get sober first, then we’ll address the depression” is not a treatment plan — it is a way of guaranteeing that neither condition improves. The untreated diagnosis destabilizes the treated one. Depression that is left alone during a 30-day residential admission drives early relapse the week the client discharges. Alcohol use that continues during an SSRI trial blunts antidepressant response and mimics treatment failure. Integration has been the SAMHSA-designated standard of care for more than two decades, and it requires clinical staff cross-trained in both domains rather than a referral chain.
Integrated treatment means the psychiatrist prescribing buprenorphine or naltrexone is the same clinician managing the sertraline, aripiprazole, or lithium. It means the therapist running CBT for depression also holds the ACT and MI conversations about ambivalence toward abstinence. It means the treatment plan sequences interventions by clinical priority — stabilize acute symptoms first, address contingencies second, process trauma when the client’s window of tolerance supports it — rather than deferring half of the picture to a referral that never materializes.
Programs that hand co-occurring clients to an outside psychiatrist “for the mental health piece” are running a two-provider handoff at exactly the moment the client is least equipped to coordinate their own care. RECO closes that handoff by keeping both providers in the same weekly clinical meeting, working from the same chart.
The high-prevalence co-occurring diagnoses
Five diagnoses account for the majority of what presents in a dual diagnosis program: major depressive disorder, post-traumatic stress disorder, generalized anxiety disorder, bipolar disorder, and adult attention-deficit/hyperactivity disorder. RECO screens all five at intake with validated instruments — the PHQ-9 for depression, the PCL-5 for PTSD, the GAD-7 for anxiety, the MDQ for bipolar spectrum illness, and the ASRS for adult ADHD — alongside CIWA-Ar for alcohol withdrawal and COWS for opioid withdrawal when detox is indicated.
Each positive screen opens a defined evidence-based pathway. Depression: SSRI or SNRI titration paired with CBT and behavioral activation, with augmentation or a switch to esketamine or ketamine infusions if two adequate antidepressant trials fail. PTSD: cognitive processing therapy, prolonged exposure, or EMDR, sequenced after acute withdrawal has resolved. Generalized anxiety disorder: CBT with interoceptive exposure, SSRI first-line, buspirone as an adjunct, benzodiazepines avoided in the substance use population. Bipolar disorder: mood stabilizer optimization — lithium, valproate, lamotrigine, or an atypical such as quetiapine or olanzapine — before any antidepressant is layered on. ADHD: non-stimulant first (atomoxetine, guanfacine, bupropion), with carefully monitored stimulant use only when abstinence is stable and the diagnosis is well documented.
Obsessive-compulsive disorder, when present, is scored on the Y-BOCS and treated with exposure and response prevention plus SSRI dosing in the OCD range. Nothing gets deferred to a follow-up appointment that may never happen.
MAT and psychotropic medication managed by one psychiatrist
Fragmented prescribing is one of the most reliable relapse pathways in this population. A primary care physician manages the antidepressant, an outside psychiatrist adjusts the mood stabilizer, a separate clinic handles MAT, and no one is looking at the full medication list. Interactions get missed. Sedating combinations accumulate. The client is caught between three prescribers who do not communicate with each other.
RECO’s in-house addiction psychiatry consolidates that prescribing. Buprenorphine or extended-release naltrexone for opioid use disorder, naltrexone or acamprosate for alcohol use disorder, and — where clinically indicated — the client’s SSRI, SNRI, mood stabilizer, antipsychotic, or ADHD medication are managed by the same physician. Drug-drug interactions are flagged in real time. QTc-prolonging combinations are avoided. Dosing is coordinated with the therapy schedule so that sedating medications do not undercut group participation.
For treatment-resistant depression that has not responded to adequate medication trials, RECO offers rTMS on a standard protocol — typically 3,000 pulses per session at 120 percent of motor threshold over a six-week course targeting the left dorsolateral prefrontal cortex — and ketamine services under psychiatric supervision. Both are folded into the same treatment plan rather than referred out.
Trauma is often the through-line
For a substantial share of dual diagnosis clients, unprocessed trauma sits upstream of both the substance use and the mood disorder. The substance is regulating something. Treating the regulation without addressing what is being regulated is why so many clients relapse within 90 days of a program that “worked.”
RECO screens for trauma at intake using the PCL-5 and a structured trauma history. Stabilization comes first — DBT skills, grounding, sleep and nutrition, medication that supports the window of tolerance — before any exposure-based work begins. Once the client can regulate, evidence-based trauma processing follows: cognitive processing therapy, prolonged exposure, or EMDR, matched to presentation and client preference. For clients whose trauma symptoms include panic and hyperarousal that block sleep, prazosin and non-benzodiazepine anxiolytics are considered.
The therapist doing the trauma work sits on the same treatment team as the psychiatrist managing MAT and the case manager coordinating aftercare. Nothing is siloed.
What to expect on the first visit from Palm Beach Gardens
The admissions process begins with a phone call and a verification of benefits, typically resolved the same day. A clinical assessment follows — biopsychosocial history, substance use timeline, psychiatric history, medication reconciliation, and a level-of-care determination scored against the six ASAM Criteria dimensions: acute intoxication and withdrawal potential, biomedical conditions, emotional/behavioral/cognitive conditions, readiness to change, relapse and continued use potential, and recovery environment.
If medical detox is indicated, admission to the detox unit is arranged directly and CIWA-Ar or COWS monitoring begins on arrival. If PHP or IOP is the appropriate starting level, programming begins within days. Palm Beach Gardens clients typically drive I-95 south to Delray for programming; on-campus housing is available for clients who prefer to stay in Delray during the residential or PHP phase rather than commute daily.
Insurance and admissions from Palm Beach Gardens
RECO Health works with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BlueCross BlueShield plans, and accepts competitive out-of-network benefits. The admissions team runs a full verification of benefits before any commitment is made, quantifying deductible status, coinsurance, out-of-pocket maximum, and prior-authorization requirements in plain numbers. For Palm Beach Gardens residents in PGA National, BallenIsles, or Mirasol, the drive to the Delray campus is under 40 minutes in typical traffic, and admissions coordinators arrange transportation when needed.
Serving residents of: BallenIsles, Frenchman's Reserve, Mirasol, Old Palm, PGA National.
If it's any of these, we can help.
From Palm Beach Gardens callers, most asked.
Does RECO Health accept my insurance for dual diagnosis treatment from Palm Beach Gardens?
How long does dual diagnosis treatment typically last?
What happens on the first visit?
How does TMS fit into dual diagnosis treatment at RECO Health?
How do I get to RECO Health from Palm Beach Gardens?
Can family be involved, and how is privacy handled?
Other palm beach gardens-area communities we serve.
Confidential. No commitment.
Tell us a little and a real human from admissions will call you back. We verify insurance benefits within minutes and tell you honestly whether RECO Health is the right fit — including if we should refer you elsewhere.


